121 related articles for article (PubMed ID: 3587729)
1. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
Monaci E; Monaci R; Giacalone G; Meoni S
Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
Friis H
Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
Qadri SM; Belobraydic KA
Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
Greenberg RN; Bollinger M; Compton J
Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of gram-negative bacilli to aminoglycosides].
Willke A; Tural D
Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
8. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
Debbia E; Soro O
Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
[TBL] [Abstract][Full Text] [Related]
10. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
11. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
[TBL] [Abstract][Full Text] [Related]
12. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
[TBL] [Abstract][Full Text] [Related]
14. Invitro comparative evaluation of aminoglycosides at a cancer centre.
Biswas SK; Kelkar RS
Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
Landinez R; Garcia M; Merino C
Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
[No Abstract] [Full Text] [Related]
16. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
Vrbová E; Uxová M; Výmola F
Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
[TBL] [Abstract][Full Text] [Related]
19. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the inhibitory and bactericidal activity of aztreonam and amikacin against gram negative aerobic bacilli.
Fung-Tomc JC; Lincourt W; Thater C; Kessler RE
Ann Clin Lab Sci; 1988; 18(6):463-7. PubMed ID: 3239949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
